Become A Research Partner

National Brain Tumor Society funds only the most promising research poised to deliver results. Our funded research has contributed to the establishment of many of what are now the top adult and pediatric brain tumor research labs across the country, as well as advances in understanding brain tumor makeup and what could drive more effective treatments.

By partnering with us and supporting our strategic initiatives, you can help advance the understanding of brain tumors, improve the availability of new treatments, and drive the discovery of a cure. Learn more about the initiatives that you can contribute to directly.

Defeat GBM

Glioblastoma multiforme (GBM) is a highly aggressive, complex, and devastating form of brain cancer, effecting hundreds of people each day. We believe it is our duty to accelerate progress against this disease so we launched the Defeat GBM Research Collaborative in 2013 with the intent to double the 5 year survival rate of GBM patients. This comes at a time when collaboration is becoming the norm and the abundance of genomic data is accelerating diagnostic, prognostic, and therapeutic progress.

Oligo Research Fund

Oligodendroglioma (oligo) is a relatively rare brain tumor representing about 6% of gliomas, with a diagnosis rate of about 1,150 patients a year in the U.S. alone. Critical research is required to deliver oligo patients new therapies that are more durable and extend their lives. In order to make effective, targeted therapies a reality it is essential to identify and understand the molecular drivers of the tumor’s genesis and maintenance, as well as resistance.

Pediatric Initiatives

Our new pediatric initiative, Project Impact, will leverage increases in knowledge gained from earlier funded research efforts, and develop a program that can address critical barriers to progress within the drug discovery and development pipeline through an integrated approach to advance research toward new treatments for pediatric brain tumor patients.

Community Research

The Community Research Fund allows contributors to pool donations to support research on a specific type of tumor. This program leverages a team of highly experienced, nationally-recognized scientific experts, working with National Brain Tumor Society staff, to determine the best investment strategy for each fund.


From the Blog

  • December 19, 2014

    Defeat GBM Research Collaborative Produces Important Discovery

    Blog_DefeatGBM_logo_565x274

    As we wrote on this blog back in May, the issue of “acquired resistance” is one of the biggest challenges in successfully treating brain tumors. Acquired resistance refers to tumor cells’ abi

    Read More

  • December 15, 2014

    A Step Toward Identifying Risk Factors for Glioma

    In 2007, the National Brain Tumor Society provided funding for an international project to search for more clues to one of the biggest mysteries of brain tumors – what causes them to develop. This week, researchers from this project, dubbed the Gliogene Consortium, published preliminary results from their study, which suggest rare mutations in a […]

    Read More

  • December 8, 2014

    National Brain Tumor Society Announces Appointment of New Chief Executive Officer

    Sally M. Davis named CEO of largest brain tumor nonprofit in the U.S. following national search National Brain Tumor Society, the largest nonprofit dedicated to the brain tumor community in the United States, has concluded its national search process and, today, announced the selection of Sally M. Davis as its new Chief Executive Officer. “National […]

    Read More

More from the blog